Insmed (INSM) PT Raised to $206 at Mizuho following positive data

March 24, 2026 8:27 AM

Mizuho analyst Graig Suvannavejh raised the price target on Insmed (NASDAQ: INSM) to $206.00 (from $204.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found